Project Value Delivered in 2021-2022
Projects spanning the life sciences and innovation sector from facility design and construction to facility startup to facility divestment and repositioning.
background image: Boston Convention Center
Let’s connect at BIO 2023
Pat Larrabee and Tim Howland will be standing up for science, innovation and truth at this year’s Bio Conference June 5 through 8 in Boston. They'd also love to sit down with you to discuss how Facility Logix can serve your needs.
Case Studies
Maxcyte® project photo
Maxcyte®
Project Size
Aggregate 53,000 SF (Phases 1-3)
Schedule
Aug 2022
On a solid foundation of more than 20 years’ experience perfecting the art of cell engineering, MaxCyte is opening exciting new possibilities in cell-based therapies with ExPERTTM instruments, bringing together best-in-class electroporation technology with seamless scalability. The challenge: Scattered operations and a lack of facility cohesion is preventing the company...
Read More about Maxcyte®
Mayo Clinic and College of Medicine project photo
Mayo Clinic and College of Medicine
Project Size
75,000 SF+
Schedule
Jan 2016 -
Jan 2021
The renowned Mayo Clinic recognized new opportunities opening in the healthcare sector as communities seek to incorporate and integrate healthcare and research facilities into their economic and social tapestries. The challenge: Discovering and realizing the potential of two world-class Mayo campuses, in Rochester and Jacksonville, in catalyzing growth and vibrancy...
Read More about Mayo Clinic and College of Medicine
1812 Ashland Accellerator project photo
1812 Ashland Accellerator
Project Size
30,000 SF
Schedule
Jun 2016
The Challenge: Johns Hopkins University’s Technology Ventures and the University’s FastForward team seek to maximize the impact of University research by facilitating the transfer of research discovery. A feasibility study conducted by Facility Logix identifies demand for early-stage lab space in the Baltimore area. FLGX&rsquo...
Read More about 1812 Ashland Accellerator
Vita Therapeutics project photo
Vita Therapeutics
Project Size
11,000 SF
Schedule
Aug 2022
Founded by industry pioneers including Dr. Doug Ethell and Robert M. Laverty, Vita Therapeutics is a cell engineering company harnessing the power of genetics to develop cellular treatment for muscular dystrophy and solid tumors. The company uses induced pluripotent stem cell technology to engineer specific cell types to replace defective...
Read More about Vita Therapeutics
Vaccitech project photo
Vaccitech
Project Size
16,000 SF
Schedule
Apr 2023
A spinout of Oxford University, Vaccitech discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious disease and cancer. In 2021, the company expanded with the acquisition of Avidia Technologies in Maryland. The challenge: With the acquisition and with six clinical candidates ready to advance to trials,...
Read More about Vaccitech
Sirnaomics project photo
Sirnaomics
Project Size
45,000 SF
Schedule
Oct 2022
Sirnaomics is clinical-stage RNA therapeutics biopharmaceutical company discovering and developing innovative drugs for treatments in cancer, fibrosis, medical aesthetics and antivirals. The challenge: With 16 clinical trials currently underway, the company needed a new headquarters and lab that would accommodate the company’s unique operational needs for a higher-than-average chemical...
Read More about Sirnaomics
On-Demand Pharmaceuticals project photo
On-Demand Pharmaceuticals
Project Size
43,000 SF
Schedule
Nov 2021
On-Demand Pharmaceuticals (ODP) is developing a mobile, vending machine-like dispensary for front-line military, first responders, and other remote locations. ODP was founded by the founding director of the DARPA Biological Technologies Office, LTC (R) Geoff Ling, M.D., Ph.D. ODP occupies the former Supernus Pharmaceuticals Rockville facility. Facility Logix...
Read More about On-Demand Pharmaceuticals
Arcellx project photo
Arcellx
Project Size
100,000 SF (Phased)
Schedule
Jun 2022
Arcellx was founded by serial entrepreneur and former Human Genome Sciences VP, David Hilbert. Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma (Frederick, MD) to enter into a co-development partnership.
...
Read More about Arcellx
United Therapeutics project photo
United Therapeutics
Project Size
28,000 SF
Schedule
Feb 2019
United Therapeutics (UT), a public biopharmaceutical company, focuses on the development and commercialization of products to address patients' unmet needs. UT created the Dinutuximab-Dedicated Oncology Medical and Analytical Laboratory (DDOMAL) to expand commercial manufacturing capacity for its pediatric high-risk neuroblastoma therapy. This project inspired a Montgomery Co. zoning amendment that...
Read More about United Therapeutics
Capital Digestive Care project photo
Capital Digestive Care
Project Size
22,000 SF
Schedule
Jul 2022
Capital Digestive Care (CDC) is the largest gastroenterology group in the Mid-Atlantic states with more than 200,000 patients each year. CDC needed a core laboratory with new technology evaluation capabilities. It recognized the need to relocate its Bowie, MD operations, consolidating independent operations along the DC beltway to support lab tech...
Read More about Capital Digestive Care
Case Studies
Maxcyte®
Project Size: Aggregate 53,000 SF (Phases 1-3)
Schedule: Aug 2022
On a solid foundation of more than 20 years’ experience perfecting the art of cell engineering, MaxCyte is opening exciting new possibilities in cell-based therapies with ExPERTTM instruments, bringing together best-in-class electroporation technology with seamless scalability. The challenge: Scattered operations and a lack of facility cohesion is preventing the company...
Read More about Maxcyte®
Mayo Clinic and College of Medicine
Project Size: 75,000 SF+
Schedule: Jan 2016 - Jan 2021
The renowned Mayo Clinic recognized new opportunities opening in the healthcare sector as communities seek to incorporate and integrate healthcare and research facilities into their economic and social tapestries. The challenge: Discovering and realizing the potential of two world-class Mayo campuses, in Rochester and Jacksonville, in catalyzing growth and vibrancy...
Read More about Mayo Clinic and College of Medicine
1812 Ashland Accellerator
Project Size: 30,000 SF
Schedule: Jun 2016
The Challenge: Johns Hopkins University’s Technology Ventures and the University’s FastForward team seek to maximize the impact of University research by facilitating the transfer of research discovery. A feasibility study conducted by Facility Logix identifies demand for early-stage lab space in the Baltimore area. FLGX&rsquo...
Read More about 1812 Ashland Accellerator
Vita Therapeutics
Project Size: 11,000 SF
Schedule: Aug 2022
Founded by industry pioneers including Dr. Doug Ethell and Robert M. Laverty, Vita Therapeutics is a cell engineering company harnessing the power of genetics to develop cellular treatment for muscular dystrophy and solid tumors. The company uses induced pluripotent stem cell technology to engineer specific cell types to replace defective...
Read More about Vita Therapeutics
Vaccitech
Project Size: 16,000 SF
Schedule: Apr 2023
A spinout of Oxford University, Vaccitech discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious disease and cancer. In 2021, the company expanded with the acquisition of Avidia Technologies in Maryland. The challenge: With the acquisition and with six clinical candidates ready to advance to trials,...
Read More about Vaccitech
Sirnaomics
Project Size: 45,000 SF
Schedule: Oct 2022
Sirnaomics is clinical-stage RNA therapeutics biopharmaceutical company discovering and developing innovative drugs for treatments in cancer, fibrosis, medical aesthetics and antivirals. The challenge: With 16 clinical trials currently underway, the company needed a new headquarters and lab that would accommodate the company’s unique operational needs for a higher-than-average chemical...
Read More about Sirnaomics
On-Demand Pharmaceuticals
Project Size: 43,000 SF
Schedule: Nov 2021
On-Demand Pharmaceuticals (ODP) is developing a mobile, vending machine-like dispensary for front-line military, first responders, and other remote locations. ODP was founded by the founding director of the DARPA Biological Technologies Office, LTC (R) Geoff Ling, M.D., Ph.D. ODP occupies the former Supernus Pharmaceuticals Rockville facility. Facility Logix...
Read More about On-Demand Pharmaceuticals
Arcellx
Project Size: 100,000 SF (Phased)
Schedule: Jun 2022
Arcellx was founded by serial entrepreneur and former Human Genome Sciences VP, David Hilbert. Arcellx is developing CAR-T technologies to tackle multiple myeloma with a more efficacious and calcitrant treatment than is currently available. Early success has allowed Arcellx and Kite Pharma (Frederick, MD) to enter into a co-development partnership.
...
Read More about Arcellx
United Therapeutics
Project Size: 28,000 SF
Schedule: Feb 2019
United Therapeutics (UT), a public biopharmaceutical company, focuses on the development and commercialization of products to address patients' unmet needs. UT created the Dinutuximab-Dedicated Oncology Medical and Analytical Laboratory (DDOMAL) to expand commercial manufacturing capacity for its pediatric high-risk neuroblastoma therapy. This project inspired a Montgomery Co. zoning amendment that...
Read More about United Therapeutics
Capital Digestive Care
Project Size: 22,000 SF
Schedule: Jul 2022
Capital Digestive Care (CDC) is the largest gastroenterology group in the Mid-Atlantic states with more than 200,000 patients each year. CDC needed a core laboratory with new technology evaluation capabilities. It recognized the need to relocate its Bowie, MD operations, consolidating independent operations along the DC beltway to support lab tech...
Read More about Capital Digestive Care
Results for Our Clients
$486M
Project Value Delivered in 2021-2022
Projects spanning the life sciences and innovation sector from facility design and construction to facility startup to facility divestment and repositioning.
$1B+
Project Value
A 20-year record that reflects our commitment to the best client outcomes as well as the independence, capabilities and expertise to deliver them.
90
Years Combined Experience
Deep experience that spans life sciences, project management and construction, and economic development all underpinning our integrated expertise.
59%
Repeat Clients in 2022
A percentage that reflects client satisfaction as well as our commitment to long-term collaborative relationships that work to realize client goals and vision.
Solutions Lead to Success
Greg Merrill
CEO and Co-Founder, Adaptive Phage Therapeutic
"It was such a successful program, working with Facility Logix. They really helped us manage costs, they kept the contractors on schedule and on time, they addressed issues, and they were a great facilitator of getting that program done quickly and on budget."Kurt Foreman
President and CEO, Delaware Prosperity Partnership
"When you think about firms or you think about people you've worked with, sometimes words come to mind. And, for me, it starts with marketplace knowledge first and foremost. Customer focus, too. They hone in on us right away and I never feel like I'm the Friday afternoon customer; I feel like we may be the only customer... I think they do a fabulous job."Michael Dombeck
Chief Operating Officer, Arcellx, Inc
“Facility Logix really took the time to understand who Arcellx is and what Arcellx is... I think they really put in the effort to understand what drives us, what we’re about, and what it would take to continue to foster that.”Nick Fullenkamp
Vice President of Corporate Development, Vaccitech
"The Facility Logix team immediately brought expertise and credibility to our project. They also are experts in project management and that came across really clear right away... They do these builds all the time and they have a level of experience that most people in our industry do not."Ron Holtz
CFO, MaxCyte®, Inc.
"The Facility Logix team really integrated with us as if they were employees of the company. They took it to heart. They treated it as if it was their own project. Being able to trust that it was managed by people who had the expertise to do it well was really important to having confidence that we were going to get to the right answer in the end."Thomas Kaufman
Associate Vice President, United Therapeutics Corporation
"Facility Logix has a really deep understanding of the life science industry and they also understand the nuts and bolts of the design and construction process for complex facilities... It's really hard to find organizations that have both of those things, very few can marry both of those uniquely challenging worlds of design and construction and running a project, and the life science industry."
background image: asdf
Why Your Organization Should Choose Facility Logix
No other company in the industry combines the depth and diversity of Facility Logix experience and expertise: Life sciences; design, program and construction management; and economic development. Build a higher-functioning environment for innovation, faster and at lower costs, and reap the benefits of a facility that works on every level to support your mission and organizational goals.
Featured Project
background image: 3d rendering of buildin interior
Arcellx Expansion
When Arcellx needed more space for laboratory and research, Facility Logix provided end-to-end service, from helping the company understand the needed specifications through design, construction and even relocation of staff.
“Facility Logix helped me stay on top of everything as we transformed an old office into a new lab that would support GMP manufacturing.”
- Michael Dombeck Chief Operating Officer, Arcellx, Inc.
Arcellx Expansion
When Arcellx needed more space for laboratory and research, Facility Logix provided end-to-end service, from helping the company understand the needed specifications through design, construction and even relocation of staff.
“Facility Logix helped me stay on top of everything as we transformed an old office into a new lab that would support GMP manufacturing.”
- Michael Dombeck Chief Operating Officer, Arcellx, Inc.Services Overview
Our Partners
background image: Patricia Larrabbee in the field
Patricia Larrabbee
Founder, President
Pat is the founder and President of Facility Logix. She has over 30 years of experience in the biotechnology industry, including several years as a bench researcher. For the past 20 years, Pat has applied her technical end-user knowledge to the facility-related needs of the industry.
Patricia Larrabbee
Founder, President
Pat is the founder and President of Facility Logix. She has over 30 years of experience in the biotechnology industry, including several years as a bench researcher. For the past 20 years, Pat has applied her technical end-user knowledge to the facility-related needs of the industry.